Related content

In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

By Prats G.   Roig C.   Miró E.   Navarro F.   Mirelis B.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 21, Iss. 4, 2002-04 ,pp. : 328-334

Springer Publishing Company

Access to resources Recommend Favorite

Antimicrobial activity of prulifloxacin in comparison with other fluoroquinolones against community-acquired urinary and respiratory pathogens isolated in Greece

By Karageorgopoulos D.   Maraki S.   Vatopoulos A.   Samonis G.   Schito G.   Falagas M.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 32, Iss. 11, 2013-11 ,pp. : 1417-1422

Springer Publishing Company

Access to resources Recommend Favorite

Review of the Comparative In vitro Susceptibilities of Lower Female Genital Tract Pathogens to Older and Newer Fluoroquinolones

By Alexander C.J.   Goldstein E.J.C.   Citron D.M.   DeCherney A.H.  

Anaerobe, Vol. 6, Iss. 6, 2000-12 ,pp. : 313-323

Academic Press

Access to resources Recommend Favorite

In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei

By Drago M.   Scaltrito M.   Morace G.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 8, 2004-08 ,pp. : 619-624

Springer Publishing Company

Access to resources Recommend Favorite

: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole

By Meaney M.   Fairweather I.   Brennan G.   Ramasamy P.   Subramanian P.  

Parasitology Research, Vol. 88, Iss. 4, 2002-04 ,pp. : 315-325

Springer Publishing Company

Access to resources Recommend Favorite